Literature DB >> 18382863

Pelvic floor muscle training in the prevention and treatment of urinary incontinence in women - what is the evidence?

Søren Brostrøm1, Gunnar Lose.   

Abstract

Many women suffer from urinary incontinence (UI). During and after pregnancy, women are advised to perform pelvic floor muscle training (PFMT) to prevent the development of UI. In established UI, PFMT is prescribed routinely as first-line treatment. Published studies are small, underpowered and of uneven methodological quality. Variations in study populations, intervention types and outcome measures make comparisons difficult. While further studies are needed, the available evidence suggests a lack of long-term efficacy of peripartum PFMT. In established UI, there seems to be a modest immediate response to PFMT. Based on the available evidence, we believe that a critical reappraisal of PFMT is needed, and judgments on the place of PFMT in current clinical practice should be reserved until further evidence, including cost-benefit analyses, has unequivocally demonstrated a clinically relevant efficacy.

Entities:  

Mesh:

Year:  2008        PMID: 18382863     DOI: 10.1080/00016340801938806

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  A randomized clinical trial comparing pelvic floor muscle training to a Pilates exercise program for improving pelvic muscle strength.

Authors:  Patrick J Culligan; Janet Scherer; Keisha Dyer; Jennifer L Priestley; Geri Guingon-White; Donna Delvecchio; Margi Vangeli
Journal:  Int Urogynecol J       Date:  2010-01-22       Impact factor: 2.894

2.  Prevalence of major levator abnormalities in symptomatic patients with an underactive pelvic floor contraction.

Authors:  Anneke B Steensma; Maja L Konstantinovic; Curt W Burger; Dirk de Ridder; Dirk Timmerman; Jan Deprest
Journal:  Int Urogynecol J       Date:  2010-03-04       Impact factor: 2.894

Review 3.  Stress urinary incontinence in pregnant women: a review of prevalence, pathophysiology, and treatment.

Authors:  Bussara Sangsawang; Nucharee Sangsawang
Journal:  Int Urogynecol J       Date:  2013-02-23       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.